We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

Back to rankings

45 hedge funds and large institutions have $88.4M invested in Neos Therapeutics, Inc in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 8

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

5% more funds holding

Funds holding: 43 → 45 (+2)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

30% less capital invested

Capital invested by funds: $127M → $88.4M (-$38.5M)

Holders
45
Holders Change
+2
Holders Change %
+4.65%
% of All Funds
1.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
18
Reduced
8
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$5.49M
2
BFA
BlackRock Fund Advisors
California
+$2.89M
3
SCM
Sio Capital Management
New York
+$1.73M
4
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$1.22M
5
EA
Emerald Advisers
Pennsylvania
+$868K

Top Sellers

Rank Fund Capital Flow
1
TCP
Tourbillon Capital Partners
New York
-$12.9M
2
PA
Perceptive Advisors
New York
-$3.45M
3
CS
Credit Suisse
Switzerland
-$2.59M
4
WRF
Waddell & Reed Financial
Kansas
-$840K
5
WSA
Wall Street Associates
California
-$754K
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$17.9M +$5.49M +363,864 +41%
DA
2
DSC Advisors
Illinois
$13.1M +$471K +31,240 +3%
SCM
3
Sio Capital Management
New York
$11.2M +$1.73M +114,785 +17%
DM
4
Deerfield Management
New York
$6.56M – – –
EMFAT
5
Emerald Mutual Fund Advisers Trust
Pennsylvania
$5.9M +$1.22M +80,916 +24%
EA
6
Emerald Advisers
Pennsylvania
$5.42M +$868K +57,561 +18%
BFA
7
BlackRock Fund Advisors
California
$4.82M +$2.89M +191,513 +132%
PI
8
Putnam Investments
Massachusetts
$3.08M – – –
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$3.04M -$44.1K -2,925 -1%
WSA
10
Wall Street Associates
California
$2.14M -$754K -50,000 -25%
PA
11
Perceptive Advisors
New York
$2.04M -$3.45M -228,463 -62%
Vanguard Group
12
Vanguard Group
Pennsylvania
$1.85M +$824K +54,614 +73%
BIT
13
BlackRock Institutional Trust
California
$1.63M +$147K +9,721 +9%
Marshall Wace
14
Marshall Wace
United Kingdom
$1.38M +$150K +9,929 +12%
DCM
15
DAFNA Capital Management
California
$908K – – –
Northern Trust
16
Northern Trust
Illinois
$902K +$777K +51,529 +450%
State Street
17
State Street
Massachusetts
$774K +$263K +17,435 +48%
CAM
18
Cormorant Asset Management
Massachusetts
$716K – – –
HCM
19
Hodges Capital Management
Texas
$716K +$754K +50,000 New
Renaissance Technologies
20
Renaissance Technologies
New York
$609K +$641K +42,500 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$525K +$1.36K +90 +0.2%
NI
22
Numeric Investors
Massachusetts
$418K +$440K +29,191 New
Citadel Advisors
23
Citadel Advisors
Florida
$374K +$393K +26,087 New
BIM
24
BlackRock Investment Management
Delaware
$285K +$8.85K +587 +3%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$237K +$72.9K +4,832 +41%
1
2 3

NEOS Hedge Fund Activity: Q4 2015 in Review

45 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q4 2015, worth a combined $88.4M — down 30% from $127M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new NEOS positions and 9 closed out — a net gain of 2 holders — while 18 added to existing stakes and 8 trimmed.

The largest buyer was Franklin Resources, adding an estimated $5.49M. The largest seller was Tourbillon Capital Partners, exiting entirely with an estimated $12.9M sold.

  • 45 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q4 2015, up from 43 in Q3 2015.
  • Funds reported $88.4M of Neos Therapeutics, Inc stock for Q4 2015, down 30% quarter-over-quarter.
  • 11 funds opened new Neos Therapeutics, Inc positions in Q4 2015 and 9 closed out, a net change of +2 holders.
  • The largest Neos Therapeutics, Inc buyer in Q4 2015 was Franklin Resources, an estimated $5.49M added.
  • The largest Neos Therapeutics, Inc seller in Q4 2015 was Tourbillon Capital Partners, an estimated $12.9M sold.

Based on aggregated 13F filings for Q4 2015.